Suppr超能文献

mTORC1 和 mTORC2 通过调节蛋白激酶 B 共同防止镉诱导的肾小管上皮细胞凋亡和急性肾损伤。

mTORC1 and mTORC2 Co-Protect against Cadmium-Induced Renal Tubular Epithelial Cell Apoptosis and Acute Kidney Injury by Regulating Protein Kinase B.

机构信息

College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu 225009, China.

Institute of Agricultural Science and Technology Development (Joint International Research Laboratory of Agriculture and Agri-Product Safety of the Ministry of Education of China), Yangzhou University, Yangzhou, Jiangsu 225009, China.

出版信息

J Agric Food Chem. 2024 Sep 11;72(36):19667-19679. doi: 10.1021/acs.jafc.4c05702. Epub 2024 Sep 1.

Abstract

The potential threat of cadmium (Cd)-induced acute kidney injury (AKI) is increasing. In this study, our primary goal was to investigate the individual roles played by mTOR complexes, specifically mTORC1 and mTORC2, in Cd-induced apoptosis in mouse kidney cells. We constructed a mouse model with specific deletion of Raptor/Rictor renal cells. Inhibitors and activators of mTORC1 or mTORC2 were also applied. The effects of protein kinase B (AKT) activation and autophagy were studied. Both mTORC1 and mTORC2 were found to mediate the antiapoptotic mechanism of renal cells by regulating the AKT activity. Inhibition of mTORC1 or mTORC2 exacerbated Cd-induced kidney cell apoptosis, suggesting that both proteins exert antiapoptotic effects under Cd exposure. We further found that the AKT activation plays a key role in mTORC1/TORC2-mediated antiapoptosis, protecting Cd-exposed kidney cells from apoptosis. We also found that mTOR activators inhibited excessive autophagy, alleviated apoptosis, and promoted cell survival. These findings provide new insights into the regulatory mechanisms of mTOR in renal diseases and provide a theoretical basis for the development of novel therapeutic strategies to treat renal injury.

摘要

镉 (Cd) 诱导的急性肾损伤 (AKI) 的潜在威胁正在增加。在这项研究中,我们的主要目标是研究 mTOR 复合物,特别是 mTORC1 和 mTORC2,在 Cd 诱导的小鼠肾细胞凋亡中的作用。我们构建了一种特异性缺失 Raptor/Rictor 肾细胞的小鼠模型。还应用了 mTORC1 或 mTORC2 的抑制剂和激活剂。研究了蛋白激酶 B (AKT) 激活和自噬的作用。发现 mTORC1 和 mTORC2 均通过调节 AKT 活性介导肾细胞的抗凋亡机制。抑制 mTORC1 或 mTORC2 加剧了 Cd 诱导的肾细胞凋亡,表明这两种蛋白在 Cd 暴露下均发挥抗凋亡作用。我们进一步发现 AKT 激活在 mTORC1/TORC2 介导的抗凋亡中起着关键作用,保护 Cd 暴露的肾细胞免受凋亡。我们还发现 mTOR 激活剂抑制过度自噬,减轻细胞凋亡,促进细胞存活。这些发现为 mTOR 在肾脏疾病中的调控机制提供了新的见解,并为开发治疗肾损伤的新治疗策略提供了理论依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34c4/11404484/442a225b83b8/jf4c05702_0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验